000 01773 a2200529 4500
005 20250517192050.0
264 0 _c20180829
008 201808s 0 0 eng d
022 _a2051-1426
024 7 _a10.1186/s40425-017-0301-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGroisberg, Roman
245 0 0 _aCharacteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.
_h[electronic resource]
260 _bJournal for immunotherapy of cancer
_c12 2017
300 _a100 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Immunological
_xtherapeutic use
650 0 4 _aCancer Vaccines
_xtherapeutic use
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMale
650 0 4 _aMedical Records
650 0 4 _aMiddle Aged
650 0 4 _aSarcoma
_xclassification
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aHong, David S
700 1 _aBehrang, Amini
700 1 _aHess, Kenneth
700 1 _aJanku, Filip
700 1 _aPiha-Paul, Sarina
700 1 _aNaing, Aung
700 1 _aFu, Siqing
700 1 _aBenjamin, Robert
700 1 _aPatel, Shreyaskumar
700 1 _aSomaiah, Neeta
700 1 _aConley, Anthony
700 1 _aMeric-Bernstam, Funda
700 1 _aSubbiah, Vivek
773 0 _tJournal for immunotherapy of cancer
_gvol. 5
_gno. 1
_gp. 100
856 4 0 _uhttps://doi.org/10.1186/s40425-017-0301-y
_zAvailable from publisher's website
999 _c27902641
_d27902641